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When a successful maze procedure provides normalsinus rhythm, avoidance of mechanical valve willprovide active life without anticoagulation. This isespecially true among patients with Marfan syn-
drome, because most of the late mortality and morbidity after
cardiac surgery in Marfan syndrome have been related to the
prosthetic valve, anticoagulation therapy, and aortic lesions, in-
cluding bleeding or dissection.1 However, the maze procedure has
not usually been performed with reconstruction of the combined
aortic and mitral valves, on the assumption that prolonged bypass
time could result in adverse outcomes. We report here the suc-
cessful surgical treatment of a patient with aortic and mitral
insufficiency and chronic atrial fibrillation.
Clinical Summary
A 43-year-old woman had a family history of Marfan syndrome.
On the electrocardiogram, sustained atrial fibrillation with an f
wave of 0.15 mV in the V1 lead was found. On echocardiography,
severe mitral regurgitation from both anterior and posterior leaflet
prolapse, primarily in the posteromedial portion, was detected. The
sinus of Valsalva was dilated to 55 mm in diameter, and the aortic
annulus was dilated to 35 mm (Figure 1). Aortic regurgitation was
mild.
Through a right-sided left atriotomy, the mitral valve was
exposed. We used paracommissural edge-to-edge sutures and
placed a 29-mm Duran ring (Medtronic, Inc, Minneapolis, Minn).
Subsequently, we performed cryoablation on the left and right atria
for the modified maze procedure (Figure 2).
The aortic valve leaflets appeared normal on gross inspection.
We performed reimplantation of the aortic valve with a 28-mm
Gelsoft graft (Vascutek Ltd, Inchinnan, United Kingdom). The
patient successfully resumed sinus rhythm, and mechanical valve
replacement was avoided. She therefore did not require anticoag-
ulation.
Discussion
As aortic surgery has improved, the life span of patients with
Marfan syndrome has been prolonged, but it is still not satisfac-
tory.1-3 Avoidance of mechanical valves and anticoagulation ther-
apy may improve quality of life for these patients. The necessary
reconstructive procedures may be technically demanding, how-
ever, and selection of appropriate patients may be difficult. In the
aortic position, valve-sparing procedures have been recommended
for patients with normal leaflets without the use of a mechanical
valve in the mitral position.4 In the mitral position, understanding
of the complicated anatomy of diseased mitral valve has improved
the quality of mitral valve repair, and intermediate-term durability
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Figure 1. Preoperative transthoracic echocardiograms. A, Aortic regurgitation was mild in central area of valve
orifice. Leaflet prolapse was not present. B, Severe mitral regurgitation resulted from anterior and posterior leaflet
prolapse. Left atrial dimension was 50 mm. LV, Left ventricle; Ao, aorta; LA, left atrium.
Brief Communications
The Journal of Thoracic and Cardiovascular Surgery ● Volume 125, Number 6 1539
has been reported as similar to that seen with non-Marfan degen-
erative disease.2,3
In our case, successful repair of valves and sinus rhythm were
all required to avoid anticoagulation therapy after the operation.
Our current maze procedure consists of pulmonary venous isola-
tion and interruption of the macro reentry circuit with cryoablation
through a standard right-sided left atriotomy.5 With this technique,
crossclamp time was reduced by 30 minutes yet achieved a recov-
ery rate of sinus rhythm comparable to that seen with the conven-
tional maze procedure in mitral valve disease.5
Most patients with Marfan syndrome are relatively young at the
maze operation. The aggressive surgical approach may therefore
be valuable to decrease the late complications associated with
anticoagulation, thus improving quality of life.
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Figure 2. Our current modification of maze procedure. LAA, Left
atrial appendage; LSA, left sinus node artery; RSA, right sinus
node artery; SVC, superior vena cava; RAA, right atrial append-
age; SN, sinus node; PSA, posterior sinus node artery; IVC, infe-
rior vena cava; MV, mitral valve; FO, fossa ovalis; TV, tricuspid
valve. From Bando K, Kobayashi J, Kosakai Y, Hirata M, Sasako Y,
Nakatani S, et al. Impact of Cox maze procedure on outcome in
patients with atrial fibrillation and mitral valve disease. J Thorac
Cardiovasc Surg. 2002;124:577. Reprinted with permission.
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